I’ve been watching this company for several months now and haven’t really had adequate funds to jump in (until now). I’m curious what you think is the likelihood of a buyout here? One of the big pharma companies would love to have an efficacious product for chronic wound care and this tech seems like it would be right in line for acquisition. Just looking for some thoughts on medium to long term here.
News 
Market Data 
Discover 
AI
